Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

OBJECTIVE: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis. DESIGN: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut
Main Authors: Münch, Andreas, Bohr, Johan, Miehlke, Stephan, Benoni, Cecilia, Olesen, Martin, Öst, Åke, Strandberg, Lars, Hellström, Per M, Hertervig, Erik, Armerding, Peter, Stehlik, Jiri, Lindberg, Greger, Björk, Jan, Lapidus, Annika, Löfberg, Robert, Bonderup, Ole, Avnström, Sören, Rössle, Martin, Dilger, Karin, Mueller, Ralph, Greinwald, Roland, Tysk, Curt, Ström, Magnus
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Inflammatory Bowel Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717436/
https://ncbi.nlm.nih.gov/pubmed/25425655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308363
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados